aid: dewpoint
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/dewpoint.png
name: Dewpoint
description: 'Dewpoint Therapeutics is a Boston-based biotechnology company, founded in 2018, that
  pioneers drug discovery based on biomolecular condensates — the membraneless compartments inside
  cells whose formation and dysregulation underlie many diseases. Its condensate platform combines
  cell biology, high-throughput screening, and machine learning to identify condensate-modulating
  drugs (c-mods) against previously undruggable targets across oncology, neurodegeneration, and
  virology. Dewpoint is backed by SoftBank Vision Fund 2 and completed a $150M Series C in 2022. The
  company operates as a therapeutics developer and, as of this profile, exposes no public developer
  API, documentation, or developer portal; this entry captures its identity within the API Evangelist
  network.'
url: https://raw.githubusercontent.com/api-evangelist/dewpoint/refs/heads/main/apis.yml
humanURL: https://dewpointx.com/
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Health Tech
- Biotech
- Drug Discovery
- Pharmaceuticals
- Life Sciences
- Machine Learning
apis: []
common:
- type: Website
  url: https://dewpointx.com/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence